Finally, there was a trend of a correlation of rarified/clonal TCRγ gene rearrangements with improved DFS (P=0.0873), but not OS, (P=0.3177) in patients with stage III ovarian carcinomas and optimal debulking surgery (Figure 4B). Here, TRGC1 is linked to ovarian carcinoma.